Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Ph...
FDA Recall #D-0389-2024 — Class III — March 4, 2024
Product Description
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Reason for Recall
Cross Contamination with Other Products:(mycophenolate mofetil).
Recalling Firm
Novitium Pharma LLC — East Windsor, NJ
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
3,940 1000-count bottles
Distribution
Nationwide in the USA
Code Information
Lot #: M23172A, Exp 01/31/2025
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.